The Safety Risk Associated With Z-Medications To Treat Insomnia In Substance Use Disorder Patients
Abstract: Z-medications are commonly prescribed in clinical practices despite the safety concerns. Although these medications are considered safer than benzodiazepines, both act on GABA-A receptors as an allosteric modulator. In clinical practice, the risk profile for both medications is not any different, particularly in substance use disorder population.
Keywords: safety / GABA / insomnia / substance / benzodiazepines / Clinical Practices / Safer / Use Disorder / Z medications
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Addiction & Addictive Disorders" .